Sequelae of Kawasaki disease in adolescents and young adults

Kawasaki Disease Research Program, Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, 92093-0609, USA.

Kawasaki disease is an acute vasculitis of unknown etiology that predominantly affects children <5 years of age. Structural damage to the coronary arteries after the acute, self-limited illness is detected by echocardiography in approximately 25% of untreated patients. The long-term effects of the acute coronary arteritis are unknown. To define the spectrum of clinical disease in young adults that can be attributed to Kawasaki disease in childhood, we performed a retrospective survey of cases reported in the English and Japanese published data of adult coronary artery disease attributed to antecedent Kawasaki disease. The mean age at presentation with cardiac sequelae was 24.7 +/- 8.4 years (range 12 to 39) for the 74 patients identified with presumed late sequelae of Kawasaki disease. Symptoms at the time of presentation with cardiac sequelae included chest pain/myocardial infarction (60.8%), arrhythmia (10.8%) and sudden death (16.2%). These symptoms were precipitated by exercise in 82% of patients. One-third of the patients in whom a chest radiograph was taken had ring calcification. Angiographic findings included coronary artery occlusion (66.1%). Extensive development of collateral vessels was reported in 44.1% of patients. Autopsy findings included coronary artery aneurysms (100%) and coronary artery occlusion (72.2%). The acute vasculitis of Kawasaki disease can result in coronary artery damage and rheologic changes predisposing to thrombus formation or progressive atherosclerotic changes that may remain clinically silent for many years. Coronary artery aneurysms and calcification on chest radiography were unusual features in this group of patients. A history of antecedent Kawasaki disease should be sought in all young adults who present with acute myocardial infarction or sudden death.

This article has been cited by other articles:

				P. Uusimaa, M. Pedersen, T. Wong, and S. Ernst Left atrial tachycardia in a patient with calcified coronary aneurysms due to Kawasaki disease Europace, October 1, 2010; 12(10): 1498 - 1500. [Abstract] [Full Text] [PDF]

				J. B. Gordon, A. M. Kahn, and J. C. Burns When Children With Kawasaki Disease Grow Up: Myocardial and Vascular Complications in Adulthood J. Am. Coll. Cardiol., November 17, 2009; 54(21): 1911 - 1920. [Abstract] [Full Text] [PDF]

				B. W. McCrindle Kawasaki Disease: A Childhood Disease With Important Consequences Into Adulthood Circulation, July 7, 2009; 120(1): 6 - 8. [Full Text] [PDF]

				Y. Mitani, H. Ohashi, H. Sawada, Y. Ikeyama, H. Hayakawa, S. Takabayashi, K. Maruyama, H. Shimpo, and Y. Komada In Vivo Plaque Composition and Morphology in Coronary Artery Lesions in Adolescents and Young Adults Long After Kawasaki Disease: A Virtual Histology-Intravascular Ultrasound Study Circulation, June 2, 2009; 119(21): 2829 - 2836. [Abstract] [Full Text] [PDF]

				H. Senzaki Long-Term Outcome of Kawasaki Disease Circulation, December 16, 2008; 118(25): 2763 - 2772. [Full Text] [PDF]

				A. F. Low, S. C. Quek, and J. Yip A case of myocardial infarction complicating Kawasaki disease. Can. Med. Assoc. J., June 20, 2006; 174(13): 1839 - 1839. [Full Text] [PDF]

				G. Simonini, C. D. Rose, A. Vierucci, F. Falcini, and B. H. Athreya Diagnosing Kawasaki syndrome: the need for a new clinical tool Rheumatology, August 1, 2005; 44(8): 959 - 961. [Full Text] [PDF]

				H. Senzaki, C.-H. Chen, H. Ishido, S. Masutani, T. Matsunaga, M. Taketazu, T. Kobayashi, N. Sasaki, S. Kyo, and Y. Yokote Arterial Hemodynamics in Patients After Kawasaki Disease Circulation, April 26, 2005; 111(16): 2119 - 2125. [Abstract] [Full Text] [PDF]

				Y. Mitani, H. Sawada, H. Hayakawa, K. Aoki, H. Ohashi, M. Matsumura, K. Kuroe, H. Shimpo, M. Nakano, and Y. Komada Elevated Levels of High-Sensitivity C-Reactive Protein and Serum Amyloid-A Late After Kawasaki Disease: Association Between Inflammation and Late Coronary Sequelae in Kawasaki Disease Circulation, January 4, 2005; 111(1): 38 - 43. [Abstract] [Full Text] [PDF]

				J. W. Newburger, M. Takahashi, M. A. Gerber, M. H. Gewitz, L. Y. Tani, J. C. Burns, S. T. Shulman, A. F. Bolger, P. Ferrieri, R. S. Baltimore, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Pediatrics, December 1, 2004; 114(6): 1708 - 1733. [Abstract] [Full Text] [PDF]

				J. W. Newburger, M. Takahashi, M. A. Gerber, M. H. Gewitz, L. Y. Tani, J. C. Burns, S. T. Shulman, A. F. Bolger, P. Ferrieri, R. S. Baltimore, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation, October 26, 2004; 110(17): 2747 - 2771. [Abstract] [Full Text] [PDF]

				Y.-f. Cheung, T.-c. Yung, S. C. F. Tam, M. H. K. Ho, and A. K. T. Chau Novel and traditional cardiovascular risk factors in children after Kawasaki disease: Implications for premature atherosclerosis J. Am. Coll. Cardiol., January 7, 2004; 43(1): 120 - 124. [Abstract] [Full Text] [PDF]

				P A Brogan, A Bose, D Burgner, D Shingadia, R Tulloh, C Michie, N Klein, R Booy, M Levin, and M J Dillon Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research Arch. Dis. Child., April 1, 2002; 86(4): 286 - 290. [Abstract] [Full Text] [PDF]

				S. Tateno, M. Terai, K. Niwa, T. Jibiki, H. Hamada, K. Yasukawa, T. Honda, S. Oana, and Y. Kohno Alleviation of Myocardial Ischemia After Kawasaki Disease by Heparin and Exercise Therapy Circulation, May 29, 2001; 103(21): 2591 - 2597. [Abstract] [Full Text] [PDF]

				A. H. Rowley, S. T. Shulman, B. T. Spike, C. A. Mask, and S. C. Baker Oligoclonal IgA Response in the Vascular Wall in Acute Kawasaki Disease J. Immunol., January 15, 2001; 166(2): 1334 - 1343. [Abstract] [Full Text] [PDF]

				G. Dohmen, M. Dahm, M. Elsner, W. Kasper, and H. Oelert Coronary artery bypass grafting in adult coronary artery disease due to suspected Kawasaki disease in childhood Ann. Thorac. Surg., November 1, 2000; 70(5): 1704 - 1706. [Abstract] [Full Text] [PDF]

				A. H. Rowley, S. T. Shulman, C. A. Mask, L. S. Finn, M. Terai, S. C. Baker, C. A. Galliani, K. Takahashi, S. Naoe, M. B. Kalelkar, et al. IgA Plasma Cell Infiltration of Proximal Respiratory Tract, Pancreas, Kidney, and Coronary Artery in Acute Kawasaki Disease The Journal of Infectious Disease, October 1, 2000; 182(4): 1183 - 1191. [Abstract] [Full Text] [PDF]

				A. Dodge-Khatami, C. Mavroudis, and C. L. Backer Congenital Heart Surgery Nomenclature and Database Project: anomalies of the coronary arteries Ann. Thorac. Surg., April 1, 2000; 69(4): S270 - S297. [Abstract] [Full Text] [PDF]

				R. K. Han, B. Sinclair, A. Newman, E. D. Silverman, G. W. Taylor, P. Walsh, and B. W. McCrindle Recognition and management of Kawasaki disease Can. Med. Assoc. J., March 21, 2000; 162(6): 807 - 812. [Abstract] [Full Text] [PDF]

				J. W Newburger and J. C Burns Kawasaki disease Vascular Medicine, August 1, 1999; 4(3): 187 - 202. [Abstract] [PDF]

				R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF]

				A. H. Rowley and S. T. Shulman Kawasaki Syndrome Clin. Microbiol. Rev., July 1, 1998; 11(3): 405 - 414. [Abstract] [Full Text] [PDF]